Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07765212
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)Eva M.M. StrijbisNot Yet RecruitingPhase 2
NCT07765212Not Yet Recruiting
Phase 2
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progre...Eva M.M. Strijbis
NCT07764536
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital ToolNational Institute of Mental Health (NIMH)Not Yet Recruiting
NCT07764536Not Yet Recruiting
—
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital...National Institute of Men...
NCT07764718
Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy Undergoing Stereo-EEG MonitoringDuke UniversityNot Yet RecruitingNot Applicable
NCT07764718Not Yet Recruiting
Not Applicable
Temporal Interference Brain Stimulation for Adults With Drug-Resistant Epilepsy...Duke University
NCT07764640
Comparison of Three Final Impression Techniques for Severely Resorbed Mandibular RidgesTanta UniversityCompletedNot Applicable
NCT07764640Completed
Not Applicable
Comparison of Three Final Impression Techniques for Severely Resorbed Mandibular...Tanta University
NCT07764705
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07764705Not Yet Recruiting
Phase 1
A Mass Balance Study of [14C]HS-10504Jiangsu Hansoh Pharmaceut...
NCT07766759
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated TriglyceridesFosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.Not Yet RecruitingPhase 1
NCT07766759Not Yet Recruiting
Phase 1
A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglyceri...Fosun Pharmaceutical Indu...
NCT07764497
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver MetastasisSunnybrook Health Sciences CentreRecruitingPhase 2
NCT07764497Recruiting
Phase 2
Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Ca...Sunnybrook Health Science...
NCT07766031
Postoperative Pain and Analgesic Use Following Lumbar Discectomy: A Comparative Study of Endoscopic Surgery and Open SurgerySaint-Gregoire Private Hospital CenterNot Yet RecruitingNot Applicable
NCT07766031Not Yet Recruiting
Not Applicable
Postoperative Pain and Analgesic Use Following Lumbar Discectomy: A Comparative...Saint-Gregoire Private Ho...
NCT07764835
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)AstraZenecaNot Yet Recruiting
NCT07764835Not Yet Recruiting
—
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patie...AstraZeneca
NCT07764549
Salivary TNF-α, FoxO-1, and SIRT-1 Levels in Periodontitis and SmokingZehra HasgülCompleted
NCT07764549Completed
—
Salivary TNF-α, FoxO-1, and SIRT-1 Levels in Periodontitis and SmokingZehra Hasgül
NCT07765914
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fudan UniversityNot Yet RecruitingPhase 3
NCT07765914Not Yet Recruiting
Phase 3
Zuberitamab in the First Episode of Paediatric Nephrotic SyndromeChildren's Hospital of Fu...
NCT07766421
Evaluation of Iopofosine I 131 vs. R-CD in WM PatientsCellectar Biosciences, Inc.Not Yet RecruitingPhase 3
NCT07766421Not Yet Recruiting
Phase 3
Evaluation of Iopofosine I 131 vs. R-CD in WM PatientsCellectar Biosciences, In...
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZenecaRecruitingPhase 3
NCT07764978Recruiting
Phase 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZeneca
NCT07766122
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFUUniversity Hospital, ToulouseNot Yet RecruitingPhase 4
NCT07766122Not Yet Recruiting
Phase 4
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostat...University Hospital, Toul...
NCT07764432
Communication and Hospice Online With Optimal Support and EngagementNational Cancer Institute (NCI)Not Yet RecruitingNot Applicable
NCT07764432Not Yet Recruiting
Not Applicable
Communication and Hospice Online With Optimal Support and EngagementNational Cancer Institute...
NCT07765862
A PROSPECTIVE, RANDOMIZED, TWO-ARM, CONTROLLED, SINGLE-BLIND, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ARTIFIX® DURAL REPAIR SEALANT GRAFT IN CRANIAL AND SPINE SURGERY (NEOFIX STUDY)Nurami Medical LtdNot Yet RecruitingNot Applicable
NCT07765862Not Yet Recruiting
Not Applicable
A PROSPECTIVE, RANDOMIZED, TWO-ARM, CONTROLLED, SINGLE-BLIND, MULTI-CENTER STUDY...Nurami Medical Ltd
NCT07766356
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07766356Not Yet Recruiting
Not Applicable
Study of Cognitive-Linguistic Profiles: The Role of Executive Control in AphasiaUniversity Hospital, Toul...
NCT07764887
Impacted Tooth Management and Osteoradionecrosis Risk in NPCAffiliated Hospital of Guilin UniversityNot Yet RecruitingNot Applicable
NCT07764887Not Yet Recruiting
Not Applicable
Impacted Tooth Management and Osteoradionecrosis Risk in NPCAffiliated Hospital of Gu...
NCT07766005
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)Spyre Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07766005Not Yet Recruiting
Phase 2
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...Spyre Therapeutics, Inc.
NCT07765524
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL AmyloidosisShenzhen Fosun Kairos Biotechnology Co., Ltd.Not Yet RecruitingPhase 1
NCT07765524Not Yet Recruiting
Phase 1
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the...Shenzhen Fosun Kairos Bio...
Result Breakdown
Not yet recruiting16 (80%)
Completed2 (10%)
Recruiting2 (10%)
not_applicable7 (35%)
Phase 23 (15%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 33 (15%)
Phase 41 (5%)